Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: J Immunol. 2023 Sep 1;211(5):711–719. doi: 10.4049/jimmunol.2300171

Figure 2.

Figure 2.

The immune dysfunctions of dendritic cells and lymphocytes during immunoparalysis. This illustrates the current understanding from combined murine and human data on the inhibitory markers, cytokines, and antibodies produced during the chronic immunoparalysis. Downward-facing arrows indicate declines, dotted lines indicate murine based mechanism. Image created with BioRender.com.